Status:
COMPLETED
A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32a
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
To analyze the HIV viral sequences present in the CD32 + CD4a + T lymphocytes of the patients who have participated in the ANRS 139 TRIO trial, always followed and in virological success, and carrying...
Detailed Description
Objectives Principal objective To analyze the HIV viral sequences present in the CD32 + CD4a + T lymphocytes of the patients who have participated in the ANRS 139 TRIO trial, always followed and in ...
Eligibility Criteria
Inclusion
- Patients who participated to ANRS139 TRIO trial, and still followed in centers
- Who remained in virological success since the participation at the trial: 90% of HIV-1 RNA level less than 50 copies/mL : one or more blips less than 1000 copies/mL are tolerated
- Genotypic resistance profiles available at baseline and before trial
- Age ≥ 18 years
- Affiliate or beneficiary of a social security system (the State Medical Aid or AME is not a social security system).
- Written informed consent signed by the person and the investigator before any exam performed in the study.
Exclusion
- HIV-1 RNA level ≥ 1000 copies/mL at least once since the end of the 139 TRIO trial
- Patient participating in another research evaluating other treatments with an exclusion period ongoing at the screening visit.
- Person under legal guardianship or deprived of liberty by a judicial or administrative decision.
Key Trial Info
Start Date :
June 28 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 25 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03298360
Start Date
June 28 2018
End Date
June 25 2020
Last Update
December 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Monsef BENKIRANE
Montpellier, France